European Heart Journal-Quality of Care and Clinical Outcomes

Papers
(The TQCC of European Heart Journal-Quality of Care and Clinical Outcomes is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Call for emergency action to limit global temperature increases, restore biodiversity, and protect health91
Ambulance drive-thru troponin, ready to go?48
Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention42
Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied36
Letter to the editor in response to Kobo et al. 202235
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor34
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease32
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis32
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events31
Secundum atrial septal defect closure in adults in the UK30
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines29
Alcoholic cardiomyopathy-attributed mortality in Europe, 2012–2028
Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings27
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes27
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations26
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings26
Quality of life and the assessment of surgical quality25
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study24
Influence of multiple risk factor control level on cardiovascular outcomes in hypertensive patients23
Cost-effectiveness of population screening for aortic stenosis22
Correction to: Trends in risk factors among young patients with acute myocardial infarction: a nationwide cohort study22
Mapping the modern heart failure epidemic: Growing burden, root causes and widening inequalities21
Economic burden of cardiovascular disease in the United Kingdom21
Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–2221
Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials20
Impact of low physical activity on cardiovascular disease across regions and demographic groups: insights from the Global Burden of Disease Study20
Contemporary trends in incident ischaemic stroke, intracranial haemorrhage, and mortality in individuals with atrial fibrillation20
Letter to the editor in response to Sengupta et al. (2022)19
Erratum to: Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data19
Rapid Assessment and Treatment In Decompensated Aortic Stenosis (ASTRID-AS study)- A pilot study18
Risk-standardized mortality metric to monitor hospital performance for chest pain presentations18
Cancer and the risk of perioperative arterial ischaemic events17
Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort17
Greenness exposure and mortality risk in a cardio-oncologic population17
The beginning of wisdom is the definition of terms: counting heart failure hospitalizations17
Heart failure with preserved ejection fraction management: a systematic review of clinical practice guidelines and recommendations17
Association of cumulative health status with subsequent mortality in patients with acute heart failure17
Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study16
Standardized and hierarchically classified heart failure and complementary disease monitoring outcome measures: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)15
Prognostic impact of anaemia in patients undergoing aortic valve replacement: a nationwide study15
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry14
Machine learning for prediction of all-cause mortality after transcatheter aortic valve implantation14
A decade of follow-up: atrial fibrillation, pulmonary pressure, and the progression of tricuspid regurgitation14
Predictive and prognostic value of different cardiac troponin assays: a nationwide register-based cohort study14
Clinical Outcomes in Hospitalized Patients with Cancer and New versus Preexistent Atrial Fibrillation14
Hospital admissions in the last year of life of patients with heart failure13
The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study13
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly 13
Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials13
Transcatheter vs. surgical mitral valve interventions in patients with prior coronary artery bypass grafting13
Periprocedural myocardial infarction after coronary artery bypass grafting: defining what matters13
Safety of AF ablation–its evolution over time and lessons from down under12
Bacteraemia and infective endocarditis following left-sided heart valve surgery12
Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries12
Association between Early Oral β-Blocker Therapy and Risk for In-Hospital Major Bleeding after Percutaneous Coronary Intervention for Acute Coronary Syndrome: Findings from CCC-ACS Project12
National health expenditure per capita is associated with CRT implantation practice: findings from the ESC CRT Survey II with 11 088 patients11
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)11
Incidence, predictors, and prognostic impact of rehospitalization after transcatheter aortic valve implantation11
Association of baseline and changes in health-related quality of life with mortality following myocardial infarction: multicentre longitudinal linked cohort study11
Quality of life and societal costs in patients with dilated cardiomyopathy11
Trends and projections of heart failure among adolescents and young adults: an in-depth analysis for the Global Burden of Disease Study 202111
Tricuspid regurgitation management: a systematic review of clinical practice guidelines and recommendations11
Implantable cardioverter defibrillators in heart failure with reduced ejection fraction after myocardial infarction: the need for contemporary evidence11
Suspected Non-ST-elevation acute coronary syndrome meeting rapid rule-out criteria: resource utilization, diagnostic yield, and clinical outcomes of hospital admission11
Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials11
Current epidemiology and management of acute heart failure: the multicenter prospective OFICA2 cohort11
Global, regional, and national burden of atrial fibrillation/flutter related to metabolic risks over three decades: estimates from the global burden of disease study 201911
Optimizing anticoagulant therapy: is pharmacist-led intervention the best10
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–201910
Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?10
Non-invasive physiological assessment of intermediate coronary stenoses from plain angiography through artificial intelligence: the STARFLOW system10
Renin–angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health reco10
Impact of COVID-19 pandemic on the incidence and prevalence of postural orthostatic tachycardia syndrome10
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Re10
Trends in atrial fibrillation-related mortality in Europe, 2008–20199
Quality of care and long-term survival after ST-elevation myocardial infarction in adults with cancer9
Current management of transition and multidisciplinary care of patients with inherited and rare cardiomyopathies in Europe: results of the European Reference Network for rare and low prevalence comple9
Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)9
Temporal trends in loss of expected lifetime associated with cardiovascular complications following newly diagnosed atrial fibrillation: a Danish nationwide cohort study from 2000 to 20229
Reperfusion strategies on the clinical outcomes of ST-elevation myocardial infarction patients over 80 years old in China9
Heart failure in an ageing world: closing the evidence-equity gap9
Trends and risk factors analysis of aortic aneurysm mortality in China over thirty years: based on the global burden of disease 2019 data8
Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI8
Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis8
Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence8
Adapting predictive risk models and preventive strategies across different socio-economic regions to reduce global cardiovascular burden8
Diagnostic accuracy, clinical characteristics, and prognostic differences of patients with acute myocarditis according to inclusion criteria8
Discharge after primary percutaneous coronary intervention: the earlier the better?8
Left ventricular thrombus in ischaemic heart disease: diagnosis, treatment, and gaps of knowledge8
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study8
Comprehensive risk factor management for hypertensive patients8
Regional disparities in heart transplant mortality in the USA8
Rigour of development of European Society of Cardiology, American College of Cardiology and American Heart Association guidelines over a 12-year period (2013–2024): a systematic review of guidelines7
The burden of atrial fibrillation related to metabolic risks: different countries and territories, yet the same challenges7
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry7
Existing heath disparities in congenital heart disease: the path forward to achieving health equity—A scientific statement of the European Association of Preventive Cardiology of the ESC7
Assessing the health impact of low seafood omega-3 intake on ischaemic heart disease: trends, demographic disparities, and forecasts7
Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study7
Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice7
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings7
Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study7
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 20407
The patient journey in chronic coronary syndromes with/without obstructive coronary arteries7
0.054797887802124